BEAM
Beam Therapeutics Inc.
Biological Products, (No Diagnostic Substances)- 売上
- $140m
- 時価総額
- $2.7bn
株価 $26.29 · 100株 2,629円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $378m | $64m | $140m |
| 成長率 | — | ▲83.2% | 120.0% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $117m | $112m | $114m |
| 販管費率 | 30.9% | 175.6% | 81.4% |
| 営利 | ▲$176m | ▲$416m | ▲$384m |
| 営利率 | ▲46.7% | ▲654.3% | ▲274.6% |
| 純利益 | ▲$133m | ▲$377m | ▲$80m |
| PBR | 2.7 | 3.6 | 2.2 |
| PSR | 7.1 | 42.1 | 19.1 |
| PGPR | — | — | — |
| PER | — | — | — |
| ﾈｯﾄｷｬｯｼｭ | $433m | $279m | $292m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲738% | ▲155% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）